Latest Miltefosine Stories
Relapses after treatment for Leishmania infection may be due to a greater infectivity of the parasite rather than drug resistance, as has been previously thought.
Researchers have identified fexinidazole as a possible, much-needed, new treatment for the parasitic disease visceral leishmaniasis.
Scientists of the Institute of Tropical Medicine (ITG) discovered a parasite that not only had developed resistance against a common medicine, but at the same time had become better in withstanding the human immune system.
Visceral Leishmaniasis program expands to support South Asian regional elimination efforts. San Francisco, CA (PRWEB) November 24, 2010 The Institute for OneWorld Health (iOWH), the US based non-profit pharmaceutical company with offices in San Francisco, USA and India that develops drugs for people with neglected infectious diseases in the developing world, today announced a new program in Nepal and Bangladesh to develop a therapy for Visceral Leishmaniasis (VL) available through a grant...
The parasite Trypanosoma cruzi (or T cruzi), which causes Chagasâ€™ disease, will go to great lengths to evade death once it has infected human host cells, researchers have discovered.
Hundreds of millions of people, mainly in developing countries, are disabled by infectious diseases, according to the World Health Organization.More than 12 million people in 88 countries are infected with leishmaniasis, a parasitic disease spread by the bite of infected sand flies. Nearly 2 million new cases are reported and about 70,000 people die from the disease annually.Researchers at the University of Illinois at Chicago have discovered that compounds derived from a natural product can...
Dutch doctors uncover medical fraud in Bangladesh BRUSSELS, Sept. 23 (Xinhua) -- Doctors from an Amsterdam hospital have sounded the alarm about a possible fraud related to medication for the potentially fatal infectious disease of leishmaniasis, Dutch paper De Telegraaf reported Tuesday.
Researchers at University of Rochester Medical Center reported yesterday a drug used to treat parasitic infections in developing countries also attacks the human immunodeficiency virus (HIV) in a new and powerful way.
A drug already used to treat parasitic infections, and once looked at for cancer, also attacks the human immunodeficiency virus (HIV) in a new and powerful way, according to research published today online in the open access journal Retrovirology.
- Growing in low tufty patches.